Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC)
Thus, PRP treatment is a promising and practical option, improving patient outcomes and reducing healthcare costs. It is an attractive choice for healthcare providers and insurers in managing non-healing diabetic foot ulcers.
Authors
- Stefano Landi (ORCID: https://orcid.org/0000-0001-9835-1877)
- Stefania Simoni (ORCID: https://orcid.org/0000-0002-6218-5042)
- Salvatore Russo (ORCID: https://orcid.org/0000-0001-8537-1852)
Institutions
- University of Verona (IT)
- University of Salento (IT)
- Ca' Foscari University of Venice (IT)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ceor.s496616
- Citations
- 6
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 7.77